MicroRNA as New Tools for Prostate Cancer Risk Assessment and Therapeutic Intervention: Results from Clinical Data Set and Patients' Samples

Prostate cancer (PCa) is one of the leading causes of cancer-related death in men. Despite considerable advances in prostate cancer early detection and clinical management, validation of new biomarkers able to predict the natural history of tumor progression is still necessary in order to reduce ove...

Descripción completa

Detalles Bibliográficos
Autores principales: Cannistraci, Alessio, Di Pace, Anna Laura, De Maria, Ruggero, Bonci, Désirée
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182080/
https://www.ncbi.nlm.nih.gov/pubmed/25309903
http://dx.doi.org/10.1155/2014/146170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182080/
https://www.ncbi.nlm.nih.gov/pubmed/25309903
http://dx.doi.org/10.1155/2014/146170

Ejemplares similares